However, genome-wide association studies of ADPKD patients in whom there is a genotype/phenotype discordance (i.e. more aggressive PKD2-associated disease) that might uncover TRPM3 as a modifier gene have not been completed. Here, TRPM3 is linked to autosomal dominant polycystic kidney disease.